Dust Management in a Pharmaceutical Environments

 

Dust Management in a Pharmaceutical Environments

A few of the most familiar unit operations such as sieving, blending, encapsulating, spray-drying, coating, mixing, table-ting, screening, milling, and conveying are processes that can initiate dust. Although dustiness is not a unique issue to the pharmaceutical formulation industry, it needs very close attention.

Various factors need to be considered, such as the prospective effects on the health of workers. Also, cross-contamination and management/retrieval must be thoroughly considered.  

Sovereign Pharmaceuticals is the number one CDMO Pharmaceutical Company in America. We are committed to exceeding quality and regulatory requirements, as well as focusing on our customers. We do this via dedicated, empowered, and motivated employees.

Pharmaceutical Dust

The release of harmful dust materials may transpire during the pharmaceutical manufacturing of products such as orally ingested powders, tablets, pills, or during the equipment cleaning process.

For this reason, one needs to understand various factors such as the physical and chemical characteristics of processed materials and other environmental interactions that may cause cross-contamination.

Other products may be contaminated and can lead to an impact on the safety and quality of products. It can also lead to a high cost of cleaning, resulting in extra downtime and wear of costly machinery.

Managing the Risks of Pharma Dust

1. A very practical approach to dust management is using a product with very low dust potential. Products with lower dust potential are easier to manage as regards the dustiness in the environment.

2. Another effective approach to dust management is ‘Source Capture.’ The ability to capture the dust during its instigation source is a practical approach. This technique involves employing several types of coverings to segregate the dust as close to the point of origin as possible. This is done to safeguard the process operator and stop the airborne dust from moving elsewhere across the facility.

3. Another effective method of dust management is via the use of filtration and extraction systems. Setting up an industrial filtration system will ensure compliance with governing standards of cross-contamination and hazardous issues.

This technique may also involve unique accessories or options to improve the reliability and safety of the filtration system. Through this, the dust-generating process can be contained from the rest of the facility while protecting the contained area.

The achievement of full regulatory compliance is based on the proper use of process instruments and equipment and also testing products both under laboratory conditions and in the work environment.

Achieving full regulatory compliance is based on the proper use of equipment and process instruments and testing both in the work environment and under laboratory conditions.  

Sovereign Pharmaceuticals is a pharmaceutical company in Texas. We stay focused on the customer. We constantly upgrade our facilities and equipment to meet our customers’ demands. We request you to visit our facilities and are open to the opportunity to talk about how we can fulfill your production and development needs. Contact us today.

How to Scale-Up from Lab to Pilot to Production

 

How to Scale-Up from Lab to Pilot to Production

It is one thing to get a pharmaceutical product to perform well in the lab and another thing to get the same result to scale up flawlessly in the production stage. In addition, factors such as altered material properties and different batch sizes can impact the performance of products.

The pilot scale-up technique is helpful to scientists, as it can help them to understand the ultimate potential of a product. In addition, because it can come in handy to know the pitfalls to avoid, we have provided a pathway to follow during this process. Keep reading to learn more about this.

Sovereign Pharmaceuticals is the number one CDMO Pharmaceutical Company in America. We are committed to exceeding quality and regulatory requirements, as well as focusing on our customers. We do this via dedicated, empowered, and motivated employees.

Pilot Scale-Up and the Processes Involved

The pilot scale-up process explains the procedures involved when developing products before formulating the first pilot-production batch. Below, we have highlighted the four primary steps to follow.

1. Choosing the formula

The first step in pilot scale-up in a pharmaceutical formulation is to choose an appropriate preliminary formula. This process will be completed in the development laboratory. Your selected formula should be one you intend to test and know more about based on factors such as initial specifications and design requirements. This formula should be referred to as your (1x) laboratory batch.

In many cases, the initial size of the laboratory batch will be:

* 3 to 10 kg of a semisolid/solid

* 3 to 10 liquid liters

* 3,000 to 10,000 capsule or tablet units

Before creating capsule or tablet units, milling must occur. During this process, the material is broken down into more uniform and smaller particles. After that, developers can compress, mix, compress, and coat the particles into the final unit dosage.

2. Creating the laboratory pilot batch of the drug product

The second step is to make a laboratory pilot batch. This batch will be (10x). Because you are multiplying your first batch by 10 to get a larger scale, your pilot laboratory batch will be:

* 30 to 100 kg of a semisolid/solid

* 30 to 100 liquid liters

* 30,000 to 100,000 capsule or tablet units

Bear in mind that these numbers are not a concrete rule but a standard. In addition, a few factors, such as the cost of your raw materials and the availability of your essential equipment, can alter your laboratory pilot batch.

3. Carrying out Stability Testing

Now that you have prepared pilot laboratory batches and instituted the process demonstration, the third step is to test advanced stability.

During this time, your product should be in its approved packaging instead of standard packaging.

4. Ongoing Pilot Production

The last and final stage is the pilot production phase. During this phase, the batch will scale up to 100x. This means that the batch will become:

* 300 to 1,000 kg of a semisolid/solid

* 300 to 1,000 liquid liters

* 300,000 to 1 million capsule or tablet units

At the end of this phase, the product passes through stability testing in approved packaging.

Sovereign Pharmaceuticals is a pharmaceutical company in Texas. We constantly upgrade our facilities and equipment to meet our customers’ demands. We request you to visit our facilities and are open to the opportunity to talk about how we can meet your production and development needs. Contact us today.

 

Advantages and Disadvantages of Contract Manufacturing

In contract manufacturing, businesses/companies do not manufacture their own products. Instead, the manufacturing activities are outsourced to contract manufacturers. Contract manufacturers are experts in the manufacturing process. They are responsible for the production of the products of other companies – based on a contract. Here, companies put their packaging and label on the products produced by contract manufacturers.

CM is beneficial to companies. This is because it focuses more on functional areas and helps to minimize cost.

Sovereign Pharmaceuticals is the number one CDMO Pharmaceutical Company in America. We are committed to exceeding quality and regulatory requirements, as well as focusing on our customers. We do this via dedicated, empowered, and motivated employees.

Today, our article has highlighted the advantages and disadvantages of contract manufacturing. To learn about this, kindly scroll down and continue reading.

Some Advantages of Contract Manufacturing

1. High-quality Products

Productions done under contract manufacturing are high-quality. This is because these manufacturers are experts and are highly skilled in manufacturing activities. They manufacture high-quality products at lower costs, helping companies to provide high-quality products to their consumers.

2. There is a Focus on Selling Activities

Pharmaceutical Contract Manufacturing helps companies to pay more attention to functional areas. One crucial task for businesses is the sales of products. For it to survive, it requires to face competition in the market. And when companies leave the task of manufacturing to CM, it gives them the time to focus more on the sales of products.

3. Easy Entry in Markets

To be able to perform business in many countries, there are many trade barriers. Not just any company can go in and sell their products. But under CM, it becomes easy for companies to have access to various countries to sell their products.

This is made possible by giving the CM job to manufacturers in this country to allow easy access.

4. Cost Savings

Contract Manufacturing helps companies to save huge capital needed for setting up the process of production. Companies are not obligated to invest huge amounts in manufacturing plants and many other kinds of equipment.

Doing this saves the company the cost of labor that is involved in training and wages. Here, the companies outsource their pharmaceutical manufacturing activities to lower-cost countries.

Some Disadvantages of Contract Manufacturing

1. Lack of Flexibility

Companies under CM lose their ability to respond to the conditions of the market. There are fluctuations in the market with regards to the demand for its products. Countries lack direct control over manufacturing activities.

Here, they are unable to affect its supply chain, making it hard for them to fulfill the demands of their customers.

2. Problems with Outsourcing

When outsourcing, companies reach out to contract manufacturers of diverse countries. These producers are from lower-cost countries. Diverse countries have different traditions, cultures, lead times, and languages.

And this diversity makes it hard for companies to manage their contract manufacturers.

3. Late Deliveries

Contract manufacturers produce goods for multiple companies, and not just one. This means that their production activity is on a large scale. And sometimes, due to the large-scale production, they may not be able to manufacture some company’s products on time.

Sovereign Pharmaceuticals is a pharmaceutical company in Texas. We constantly upgrade our facilities and equipment to meet our customers’ demands. We request you to visit our facilities and are open to the opportunity to talk about how we can meet your production and development needs. Contact us today.

 

The Future of Contract Manufacturing

Pharmas have been laden with high financial performance. This is especially true in the world of buying and running pricey equipment for the mass manufacturing of pharmaceuticals. To fight this, many businesses have started to outsource their manufacturing to contract manufacturers (CM) who have the facilities, equipment, and labor force to run a more cost-effective manufacturing.

Partnering with the proper CM is starting to become a practical trend among companies. Today, we have highlighted some developments we expect to see in CM for the pharmaceutical industry.

Sovereign Pharmaceuticals is the number one CDMO Pharmaceutical Company in America. We are committed to exceeding quality and regulatory requirements, as well as focusing on our customers. We do this via dedicated, empowered, and motivated employees.

1. Improving Performance with Better e-platforms

Many contract manufacturers are integrating artificial intelligence, as well as other technological innovations, to speed up their time of production. Digitizing CDMOs/CMOs will significantly account for higher efficiency in the delivery of products to clients.  

2. Secured Channels for Supply Chains

Notwithstanding its obvious advantages, electronic communication may pose risks to the future of CM. Third-party producers naturally use systems that protect the designs of sensitive and production information from malicious beings.  

3. Real-time, remote tracing

To track the production process, pharmaceutical companies supervise and audit their contract manufacturer’s manufacturing and delivery process. However, as Contract Manufacturing revolutionizes its procedures, product conditions can now be remotely checked.

This kind of real-time monitoring is made possible by the IoT, which allows pharmaceutical supply chain companies to share data and quickly respond to any events or issues. This will help pharmaceutical industries to better oversee the production process and supply chain.

4. The Introduction of Blockchain

Any way in which CM models are making the features of technology safer is by integrating cybersecurity mechanisms such as blockchain.

The use of blockchain’s ledger system will enable businesses in the pharmaceutical blockchain to scan and record barcodes at every step.

Blockchain can also help in the incorporation of sensors into the supply chain. Humidity and temperature can be keyed in the ledger system. And this is crucial for medicines that are temperature-sensitive, such as insulin.

Through this, blockchain streamlines and secures the pharmaceutical supply chain by letting everyone that is involved to monitor every step of the drug’s journey.

5. Specialized services for certain niches

Creating personalized medicines for small-batch pharmaceutical manufacturing is readily housed by CMOs in the pharmaceutical industry. Personalized or precision medicines erase “one size fits all” treatment options for people facing particular diseases or illnesses.

The ability to meet these medical conditions needs the pharma producing process to adapt to small sets of products.

6. Late-stage Customization

Late-stage customization is the final development seen in Pharmaceutical Contract Manufacturing. This is especially true when the manufacturing of a particular product is only pre-assembled. Not only does this limit the possibilities of errors taking place. However, the most significant advantage of late-stage customization is making sure that all packaging and labels are compliant with current legislation.

Sovereign Pharmaceuticals stays focused on the customer. We constantly upgrade our facilities and equipment to meet our customers’ demands. We request you to visit our facilities and are open to the opportunity to talk about how we can meet your production and development needs. Contact us today.